Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.
The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome. Blood. 2010 Apr 08; 115(14):2827-34.
View in:
PubMed
subject areas
Bone Marrow Cells
Cell Adhesion
Cell Line, Tumor
Cell Survival
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Multiple Myeloma
Mutation
Plasma Cells
Proteasome Endopeptidase Complex
Protein Inhibitors of Activated STAT
Protein Processing, Post-Translational
Small Ubiquitin-Related Modifier Proteins
Stem Cell Transplantation
Stromal Cells
SUMO-1 Protein
Transplantation, Homologous
Ubiquitin-Conjugating Enzymes
authors with profiles
Yu-Tzu Tai, Ph.D.
Kenneth Carl Anderson, M.D.
Mariateresa Fulciniti, Ph.D.
Rao H Prabhala, Ph.D.
Nikhil C Munshi, M.D., M.B.,B.S.